NVDA Price Target Hikes, STUB Shows No Guidance, MRK Buying CDTX

Nvidia (NVDA) got bullish momentum from Wells Fargo and Morgan Stanley ahead of next week's earnings. Diane King Hall talks about what analysts expect from Nvidia's long-term prospects. StubHub (STUB) sunk more than 27% following its worse-than-expected earnings and lack of guidance. Diane later eyes mergers and acquisitions as Merck (MRK) seeks to buy Cidara Therapeutics (CDTX) for $9.2 billion.

Opening Bell With Nicole Petallides

14 Nov 2025

SHARE

Schwab Network's Newsletters

Daily insights for every investor